Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $1,119.00
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given a consensus rating of “Moderate Buy” by the twenty-two brokerages that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, four have given a hold rating, sixteen have given a buy rating and […]
10 Oct 05:31 · The Cerbat Gem